Overview
- Funding agency
- National Institutes of Health
- Source
- Grants.gov
- Opportunity #
- PAR-25-311
- Funding instrument
- Cooperative Agreement
- Notice type
- Cooperative Agreement
- Actionability
- Open for response
- Lifecycle
- Open
OIP / Government Intelligence
Preparing the stored Government Intelligence discovery view.
OIP / Government Intelligence / Opportunity detail
Source: Stored live-derived Government dataNational Institutes of Health
OIP derived this review page from stored live-derived Government Intelligence source records. The official source and issuing agency remain authoritative.
Opportunity Intelligence Platform is an independent service and is not affiliated with or endorsed by the U.S. Government. Official notices, amendments, attachments, eligibility requirements, funding terms, and deadlines remain under source control.
OIP scores and explanations are informational and do not guarantee eligibility, suitability, compliance, contract award, or financial outcome.
For profit organizations other than small businesses; Public housing authorities/Indian housing authorities; Independent school districts; State governments; Native American tribal organizations (other than Federally recognized tribal governments); Private institutions of higher education; Small businesses; City or township governments; Public and State controlled institutions of higher education; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Special district governments; Native American tribal governments (Federally recognized); Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; County governments; Others (see text field entitled "Additional Information on Eligibility" for clarification)
4 warning(s) require review.
Objective score, derived by OIP · How it works
Publication decision: Publish with warning
Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) -- a Cooperative Agreement (Cooperative Agreement) issued by National Institutes of Health.
Objective Government score 63 for grants-gov-357730, computed from source evidence and Government scoring configuration.
novelty (insufficient_evidence): novelty could not be scored: no current Government source provides a reliable per-record signal for whether an opportunity is genuinely novel versus long-standing.
12 evidence record(s) support this pipeline result.
Next action: Review the official Grants.gov opportunity and follow the listed application package instructions.
95/100 · Ok
evidence_quality reflects a federal-source baseline plus completeness of deadline, funding value, eligibility, and official-source fields on this specific record.
90/100 · Ok
confidence reflects OIP's confidence in its own interpretation of this record's lifecycle and funding-value status, not confidence that any applicant will qualify.
98/100 · Ok
potential_value reflects the disclosed award ceiling or floor for this specific opportunity.
48/100 · Ok
urgency reflects the number of days remaining until the disclosed application deadline.
70/100 · Ok
difficulty reflects this opportunity's cooperative-agreement funding instrument, which typically involves substantial federal involvement and negotiation.
55/100 · Ok
time_required reflects the coordination and negotiation overhead typical of a cooperative-agreement funding instrument.
55/100 · Ok
capital_required reflects that cooperative agreements often require applicant cost-sharing as a matter of federal funding-mechanism convention; confirm the exact requirement in the official notice.
50/100 · Ok
risk reflects the number of material evidence gaps on this record (undisclosed value, missing deadline, unlisted eligibility, or a stale source date), not ordinary competitive uncertainty.
Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)
$.detail.opportunityTitle · Field Mapping · 98/100 confidence
357730 / PAR-25-311
$.detail.id · Field Mapping · 99/100 confidence
National Institutes of Health
$.detail.synopsis.agencyName · Field Mapping · 97/100 confidence
Cooperative Agreement
$.detail.synopsis.fundingInstruments · Field Mapping · 96/100 confidence
The purpose of this Notice of Funding Opportunity (NOFO) is to leverage NICHD clinical research Network infrastructure relevant to infants, children, women, pregnant and lactating women, and persons with disabilities to conduct innovative, multisite, investigator-initiated clinical trials and observational studies. This NOFO will utilize a bi-phasic (UG3/UH3), milestone-driven mechanism consisting of a start-up phase (UG3) and a full enrollment and clinical trial implementation phase (UH3). Applications submitted in response to this NOFO must address specific aims and milestones for both the UG3 and UH3 phases. A UG3 project (phase I) that meets its milestones will be administratively considered by NICHD and prioritized for transition to the UH3 award (phase II). This NOFO provides an opportunity to leverage NICHD clinical research Network infrastructure as a platform for investigator-initiated innovative hypotheses by any investigator in the extramural community. Applications must be submitted as investigator-initiated, multi-Project Director/Principal Investigator (PD/PI) grant applications in conjunction with the respective NICHD-supported Network Data Coordinating Center (DCC), or equivalent as determined by the NICHD.
$.detail.synopsis.synopsisDesc · Field Mapping · 94/100 confidence
2024-12-16T05:00:00.000Z
$.detail.synopsis.postingDate · Field Mapping · 96/100 confidence
2027-11-15T00:00:00.000Z
$.searchHit.closeDate · Field Mapping · 92/100 confidence
Applicant types: For profit organizations other than small businesses; Public housing authorities/Indian housing authorities; Independent school districts; State governments; Native American tribal organizations (other than Federally recognized tribal governments); Private institutions of higher education; Small businesses; City or township governments; Public and State controlled institutions of higher education; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Special district governments; Native American tribal governments (Federally recognized); Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; County governments; Others (see text field entitled "Additional Information on Eligibility" for clarification)
Official source materials control eligibility, deadlines, amendments, attachments, and funding terms.
Open official sourceNo numeric value · Insufficient Evidence
novelty could not be scored: no current Government source provides a reliable per-record signal for whether an opportunity is genuinely novel versus long-standing.
$.detail.synopsis.applicantTypes · Field Mapping · 94/100 confidence
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
$.detail.synopsis.applicantEligibilityDesc · Field Mapping · 94/100 confidence
6250000.00
$.detail.synopsis.awardCeiling · Field Mapping · 92/100 confidence
2025-03-31T21:04:34.000Z
$.detail.synopsis.lastUpdatedDate · Field Mapping · 88/100 confidence
PAR-25-311-Full-Announcement.html
$.detail.synopsisAttachmentFolders[0].synopsisAttachments[0] · Field Mapping · 90/100 confidence